981
Views
288
CrossRef citations to date
0
Altmetric
Review

Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review

, &
Pages 3921-3935 | Published online: 04 Jul 2018

References

  • SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
  • KuppensIEBoschTMvan MaanenMJOral bioavailability of docetaxel in combination with OC144-093 (ONT-093)Cancer Chemother Pharmacol2005551727815316750
  • VandanaMSahooSKLong circulation and cytotoxicity of PEGylated gemcitabine and its potential for the treatment of pancreatic cancerBiomaterials201031359340935620851464
  • YuHTangZZhangDPharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapyJ Control Release2015205899725529533
  • ChoKWangXNieSChenZGShinDMTherapeutic nanoparticles for drug delivery in cancerClin Cancer Res20081451310131618316549
  • ZhuangYDengHSuYAptamer-functionalized and backbone redox-responsive hyperbranched polymer for targeted drug delivery in cancer therapyBiomacromolecules20161762050206227113017
  • WuGWangZBianXDuXWeiCFolate-modified doxorubicin-loaded nanoparticles for tumor-targeted therapyPharm Biol201452897898225017652
  • QiXFanYHeHWuZHyaluronic acid-grafted polyamidoamine dendrimers enable long circulation and active tumor targeting simultaneouslyCarbohydr Polym201512623123925933544
  • WangYSongDCostanzaFTargeted delivery of tanshinone IIA-conjugated mPEG-PLGA-PLL-cRGD nanoparticles to hepatocellular carcinomaJ Biomed Nanotechnol201410113244325226000384
  • ZhaoYLinDWuFDiscovery and in vivo evaluation of novel RGD-modified lipid-polymer hybrid nanoparticles for targeted drug deliveryInt J Mol Sci20141510175651757625268623
  • YangBNiXChenLHonokiol-loaded polymeric nanoparticles: an active targeting drug delivery system for the treatment of nasopharyngeal carcinomaDrug Deliv201724166066928368206
  • GrayBPMcGuireMJBrownKCA liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or densityPLoS One201388e7293824009717
  • GaoHZhangSYangZCaoSJiangXPangZIn vitro and in vivo intracellular distribution and anti-glioblastoma effects of docetaxel-loaded nanoparticles functioned with IL-13 peptideInt J Pharm20144661–281724607217
  • NamgungRMi LeeYKimJPoly-cyclodextrin and poly-paclitaxel nano-assembly for anticancer therapyNat Commun20145370224805848
  • YangNJiangYZhangHActive targeting docetaxel-PLA nanoparticles eradicate circulating lung cancer stem-like cells and inhibit liver metastasisMol Pharm201512123223925418453
  • HongMZhuSJiangYNovel anti-tumor strategy: PEG-hydroxycamptothecin conjugate loaded transferrin-PEG-nanoparticlesJ Control Release20101411222919735683
  • NagMGajbhiyeVKesharwaniPJainNKTransferrin functionalized chitosan-PEG nanoparticles for targeted delivery of paclitaxel to cancer cellsColloids Surf B Biointerfaces201614836337027632697
  • JiangXShaXXinHSelf-aggregated pegylated poly (trim-ethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumorsBiomaterials201132359457946921911250
  • NazliCDemirerGSYarYAcarHYKizilelSTargeted delivery of doxorubicin into tumor cells via MMP-sensitive PEG hydrogel-coated magnetic iron oxide nanoparticles (MIONPs)Colloids Surf B Biointerfaces201412267468325183059
  • GaoYZhouYZhaoLEnhanced antitumor efficacy by cyclic RGDyK-conjugated and paclitaxel-loaded pH-responsive polymeric micellesActa Biomater20152312713526013038
  • HuGZhangHZhangLRuanSHeQGaoHIntegrin-mediated active tumor targeting and tumor microenvironment response dendrimer-gelatin nanoparticles for drug delivery and tumor treatmentInt J Pharm201549621057106826598487
  • KulhariHPoojaDShrivastavaSNaiduVGMSistlaRPeptide conjugated polymeric nanoparticles as a carrier for targeted delivery of docetaxelColloids Surf B Biointerfaces201411716617324632389
  • LiuCWLinWJPolymeric nanoparticles conjugate a novel heptapeptide as an epidermal growth factor receptor-active targeting ligand for doxorubicinInt J Nanomedicine201274749476722973097
  • TaheriADinarvandRAtyabiFEnhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptideInt J Mol Sci20111274591460821845098
  • HuGChunXWangYHeQGaoHPeptide mediated active targeting and intelligent particle size reduction-mediated enhanced penetrating of fabricated nanoparticles for triple-negative breast cancer treatmentOncotarget2015638412584127426517810
  • CaiLQiuNLiXA novel truncated basic fibroblast growth factor fragment-conjugated poly (ethylene glycol)-cholesterol amphiphilic polymeric drug delivery system for targeting to the FGFR-overexpressing tumor cellsInt J Pharm20114081–217318221277964
  • YinSHuaiJChenXIntracellular delivery and antitumor effects of a redox-responsive polymeric paclitaxel conjugate based on hyaluronic acidActa Biomater20152627428526300335
  • SuhMSShenJKuhnLTBurgessDJLayer-by-layer nanoparticle platform for cancer active targetingInt J Pharm20175171–2586627923697
  • FreagMSElnaggarYSAbdelmonsifDAAbdallahOYLayer-by-layer-coated lyotropic liquid crystalline nanoparticles for active tumor targeting of rapamycinNanomedicine (Lond)201611222975299627785978
  • UpadhyayKKMishraAKChuttaniKThe in vivo behavior and antitumor activity of doxorubicin-loaded poly (γ-benzyl l-glutamate)-block-hyaluronan polymersomes in Ehrlich ascites tumor-bearing BalB/c miceNanomedicine201281718021703363
  • MizrahySGoldsmithMLeviatan-Ben-AryeSTumor targeting profiling of hyaluronan-coated lipid based-nanoparticlesNanoscale2014673742375224569711
  • XiongHDuSNiJZhouJYaoJMitochondria and nuclei dual-targeted heterogeneous hydroxyapatite nanoparticles for enhancing therapeutic efficacy of doxorubicinBiomaterials201694708327105438
  • ChoHJYoonISYoonHYPolyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicinBiomaterials20123341190120022074664
  • ZhongYZhangJChengRReversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenograftsJ Control Release201520514415425596560
  • SunBDengCMengFZhangJZhongZRobust, active tumor-targeting and fast bioresponsive anticancer nanotherapeutics based on natural endogenous materialsActa Biomater20164522323327576338
  • TaoWZhangJZengXBlended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapyAdv Healthc Mater2015481203121425800699
  • ChengLHuQChengLConstruction and evaluation of PAMAM-DOX conjugates with superior tumor recognition and intracellular acid-triggered drug release propertiesColloids Surf B Biointerfaces2015136374526360738
  • DubeyRDAlamNSanejaADevelopment and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabineInt J Pharm20154921–2809126165611
  • JiJZuoPWangYLEnhanced antiproliferative effect of carboplatin in cervical cancer cells utilizing folate-grafted polymeric nanoparticlesNanoscale Res Lett201510145326608536
  • YeWLDuJBZhangBLCellular uptake and antitumor activity of DOX-hyd-PEG-FA nanoparticlesPLoS One201495e9735824828815
  • MorelliCMarisPSisciDPEG-templated mesoporous silica nanoparticles exclusively target cancer cellsNanoscale2011383198320721725561
  • YinJJSharmaSShumyakSPSynthesis and biological evaluation of novel folic acid receptor-targeted, β-cyclodextrin-based drug complexes for cancer treatmentPLoS One201385e6228923658721
  • LiangCYangYLingYHuangYLiTLiXImproved therapeutic effect of folate-decorated PLGA-PEG nanoparticles for endometrial carcinomaBioorg Med Chem201119134057406621641806
  • McCarronPAMaroufWMQuinnDJAntibody targeting of camptothecin-loaded PLGA nanoparticles to tumor cellsBioconjug Chem20081981561156918627195
  • JiangSWangXZhangZCD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cellsInt J Nanomedicine20161155055518 eCollection 201627843311
  • TrabuloSAiresAAicherAHeeschenCCortajarenaALMultifunctionalized iron oxide nanoparticles for selective targeting of pancreatic cancer cellsBiochim Biophys Acta2017186161597160528161480
  • AcharyaSDilnawazFSahooSKTargeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapyBiomaterials200930295737575019631377
  • KouchakzadehHShojaosadatiSAMohammadnejadJPaknejadMRasaeeMJAttachment of an anti-MUC1 monoclonal antibody to 5-FU loaded BSA nanoparticles for active targeting of breast cancer cellsHum Antibodies2012213–4495623549021
  • AlibolandiMRamezaniMAbnousKHadizadehFAS1411 Aptamer-decorated biodegradable polyethylene glycol-poly(lactic-co-glycolic acid) nanopolymersomes for the targeted delivery of gemcitabine to non-small cell lung cancer in vitroJ Pharm Sci201610551741175027039356
  • ZhangFCorreiaAMäkiläEReceptor-mediated surface charge inversion platform based on porous silicon nanoparticles for efficient cancer cell recognition and combination therapyACS Appl Mater Interfaces2017911100341004628248078
  • XuGYuXZhangJRobust aptamer–polydopamine-functionalized M-PLGA–TPGS nanoparticles for targeted delivery of docetaxel and enhanced cervical cancer therapyInt J Nanomedicine2016112953296527382282
  • LiXZhuXQiuLConstructing aptamer anchored nanovesicles for enhanced tumor penetration and cellular uptake of water soluble chemotherapeuticsActa Biomater20163526927926873366
  • MouQMaYZhuXYanDA small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapyJ Control Release2016230344427040815
  • SinghBJangYMaharjanSCombination therapy with doxorubicin-loaded galactosylated poly(ethyleneglycol)-lithocholic acid to suppress the tumor growth in an orthotopic mouse model of liver cancerBiomaterials201711613014427914985
  • YuCYWangYMLiNMIn vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapyMol Pharm201411263864424383625
  • LiangHFChenSCChenMCLeePWChenCTSungHWPaclitaxel-loaded poly(gamma-glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system against cultured HepG2 cellsBioconjug Chem200617229129916536458
  • JainAKesharwaniPGargNKGalactose engineered solid lipid nanoparticles for targeted delivery of doxorubicinColloids Surf B Biointerfaces2015134475826142628
  • SandovalMASloatBRLansakara-PDSEGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activityJ Control Release2012157228729621871505
  • TalelliMOliveiraSRijckenCJIntrinsically active nanobody-modified polymeric micelles for tumor-targeted combination therapyBiomaterials20133441255126023122804
  • LeeJYChungSJChoHJKimDDBile acid-conjugated chondroi-tin sulfate A-based nanoparticles for tumor-targeted anticancer drug deliveryEur J Pharm Biopharm20159453254126149228
  • ChenCHuHQiaoMAnti-tumor activity of paclitaxel through dual-targeting lipoprotein-mimicking nanocarrierJ Drug Target201523431132225539074
  • ZhangLYaoJZhouJWangTZhangQGlycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugsInt J Pharm20134411–265466423117024
  • KesharwaniPBanerjeeSPadhyeSSarkarFHIyerAKHyaluronic acid engineered nanomicelles loaded with 3,4-difluorobenzylidene curcumin for targeted killing of CD44+ stem-like pancreatic cancer cellsBiomacromolecules20151693042305326302089
  • ThamakeSIRautSLRanjanAPGryczynskiZVishwanathaJKSurface functionalization of PLGA nanoparticles by non-covalent insertion of a homo-bifunctional spacer for active targeting in cancer therapyNanotechnology201122303510121149963
  • LiLXiangDShigdarSEpithelial cell adhesion molecule aptamer functionalized PLGA-lecithin-curcumin-PEG nanoparticles for targeted drug delivery to human colorectal adenocarcinoma cellsInt J Nanomedicine201491083109624591829
  • JeongJYHongEHLeeSYBoronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetrationActa Biomater20175341442628216300
  • BazakRHouriMEl AchySKamelSRefaatTCancer active targeting by nanoparticles: a comprehensive review of literatureJ Cancer Res Clin Oncol2015141576978425005786
  • CornelioDBRoeslerRSchwartsmannGGastrin-releasing peptide receptor as a molecular target in experimental anticancer therapyAnn Oncol20071891457146617351255
  • MasterAMSen GuptaAEGF receptor-targeted nanocarriers for enhanced cancer treatmentNanomedicine (Lond)20127121895190623249333
  • KapoorAKumarSCancer stem cell: a rogue responsible for tumor development and metastasisIndian J Cancer201451328228925494123
  • ZwickeGLMansooriGAJefferyCJUtilizing the folate receptor for active targeting of cancer nanotherapeuticsNano Reviews2012310.3402/nano.v3403i3400.18496
  • RodzinskiAGuduruRLiangPTargeted and controlled anticancer drug delivery and release with magnetoelectric nanoparticlesSci Rep201662086726875783